Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 7,500 shares at $59.59 ($445K) on 2018-10-15, disclosed to the SEC on 2018-10-17.
Open-market sale of $445k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.93 | 2,500 | $147K | 33.1% |
| 2 | $59.59 | 5,000 | $298K | 66.9% |
| Total | $59.37 avg | 7,500 | $445K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |